AllianceBernstein’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$231K Buy
+7,460
New +$219K ﹤0.01% 3103
2022
Q2
Sell
-2,525
Closed -$40K 3403
2022
Q1
$40K Sell
2,525
-233
-8% -$4.82K ﹤0.01% 3190
2021
Q4
$127K Sell
2,758
-209
-7% -$12K ﹤0.01% 3162
2021
Q3
$199K Hold
2,967
﹤0.01% 3092
2021
Q2
$316K Buy
2,967
+600
+25% +$71.1K ﹤0.01% 2988
2021
Q1
$360K Hold
2,367
﹤0.01% 2829
2020
Q4
$396K Hold
2,367
﹤0.01% 2704
2020
Q3
$370K Sell
2,367
-133
-5% -$26.8K ﹤0.01% 2693
2020
Q2
$524K Buy
2,500
+133
+6% +$27.4K ﹤0.01% 2579
2020
Q1
$442K Hold
2,367
﹤0.01% 2414
2019
Q4
$572K Hold
2,367
﹤0.01% 2490
2019
Q3
$401K Buy
2,367
+1,067
+82% +$242K ﹤0.01% 2668
2019
Q2
$254K Buy
1,300
+433
+50% +$93.4K ﹤0.01% 2885
2019
Q1
$229K Buy
+867
New +$158K ﹤0.01% 2866

Other funds holding TECX

AllianceBernstein's TECX Position: Q2 2026 in Review

AllianceBernstein opened a new position in Tectonic Therapeutic (TECX) in Q2 2026: 7,460 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #3103 among its holdings. This is a return to the name: AllianceBernstein previously reported a position in TECX as recently as Q1 2022.

AllianceBernstein first reported a position in TECX in Q1 2019 and has held it in 14 quarters since. The position peaked at $572K in Q4 2019. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • AllianceBernstein held 7,460 shares of Tectonic Therapeutic worth $231K as of Q2 2026.
  • Tectonic Therapeutic was a new AllianceBernstein position in Q2 2026.
  • Tectonic Therapeutic made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #3103 holding.
  • AllianceBernstein first reported a position in Tectonic Therapeutic in Q1 2019 and has held it in 14 quarters since.
  • AllianceBernstein's Tectonic Therapeutic position peaked at $572K in Q4 2019.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.